Skip to content Skip to menu

Global medicines industry updates Code of Practice

Tuesday, 6 March 2012

Media Release

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has announced the revision and expansion of its Code of Practice which governs how companies interact with healthcare professionals and patient organisations.

The Code of Practice, which Medicines Australia helped draft, ensures that engagements with healthcare professionals are undertaken ethically. Under the Code, the provision of company-sponsored entertainment and personal gifts are banned.

Medicines Australia chief executive Dr Brendan Shaw said the IFPMA Code set the principles for the ethical standards expected of the medicines industry globally, and that some countries such as Australia have a more detailed and specific set of standards of conduct in place.

“Medicines Australia endorses the new expanded IFPMA Code of Practice, but our own Code of Conduct goes some way further,” Dr Shaw said.

”The Medicines Australia Code describes in detail the standards expected of companies when interacting with health consumer organisations and individual consumers. It also reinforces specific Australian laws that prohibit advertising prescription medicines to consumers.

“The important interactions between pharmaceutical manufacturers and healthcare professionals mean that prescribers are kept up to date with the latest information about how medicines work.

“Governments, doctors and patients must have confidence that those interactions meet the highest ethical standard. Both the Medicines Australia Code of Conduct and the IFPMA Code of Practice exist to provide that confidence.”

Medicines Australia regularly reviews its own Code of Conduct to ensure it continues to reflect changing community expectations.

A current review of Medicines Australia’s Code of Conduct will be completed by June 2012. The updated Medicines Australia Code of Conduct is expected to be implemented in January 2013.

More information about the IFPMA Code of Practice can be found on their website



Contact Person:

Jamie Nicholson
Media Communications Manager
Phone: 0419 220 293


As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at